This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,743.79 firm fixed-price delivery order is for the supply of 4,567,202,446 units of the drug Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product. The fixed-price delivery order, valued at $24,949.38, has a period of performance through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of 4,567,617,245 units of the pharmaceutical product Nitazoxanide 500 mg tablet. The contract, with a ceiling value of $42,938.91, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of March 19, 2025. This award is not designated as a set-aside...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FJL53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $5,336.03 firm fixed-price delivery order is for the supply of 4,565,265,357 units of the pharmaceutical product Nitazoxanide 500 mg Tablets. This award has an ultimate completion date of July 29, 2024 and was issued on July 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite...
This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $1,568.33 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. The contract has an ultimate completion date of March 21, 2023 and was not designated with a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $1,189.00, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies, including...
This federal contract award, valued at $82,024.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $3,037.48 with a firm fixed price, and it has an ultimate completion date of July 10, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $3,476.04 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
This federal contract award is for pharmaceutical and medical supply products provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,497.65 Delivery Order was awarded by the Defense Logistics Agency (DLA) on June 7, 2021, with a completion date of June 8, 2021. The contract is a Firm Fixed Price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...